Pricing Divergence Amid Liquidity Shifts: A Microcosm of Cross-Border RisksGlobal Report·Jul 9 at 09:02 PMXYF+1.01%BQ-5.37%
The AI Hustle and Old Economy Debris: What Happens in the Market's Forgotten CornersGlobal Report·Jul 9 at 05:03 AMBTBT-6.92%XYF+1.01%
The 2026 Barbell Market: Value Chain Ascension and the Restructuring TailGlobal Report·Jul 8 at 10:32 PMBAYZF+1.78%TRON-7.01%
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon | BAYRY Stock NewsStockTitan·Jul 1 at 09:33 AMBAYNBAYRY+1.11%
Managers' transactions announcement according to article 19 MARpressetext·Jul 1 at 09:35 AMBAYZF+1.78%BAYN
Bayer Wins Legal Fight in Bid for $7.25 Billion Roundup Settlement ApprovalCoinLive·Jun 17 at 09:58 PMBAYZF+1.78%BAYN
Key facts: Bayer Opposes $7.25B Roundup Transfer; Farm Bill ThreatensTradingView·Jun 3 at 12:13 AMBAYRY+1.11%BAYN
Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. SettlementMorningStar·Jun 2 at 06:26 AMBAYZF+1.78%BAYRY+1.11%
Bayer's Q1 Profit Surpasses Expectations Due to Strong Crop Science PerformanceCoinLive·May 12 at 01:07 AMBAYZF+1.78%BAYRY+1.11%
<![CDATA[Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-PNPLA3]]>Pharmexec·May 6 at 08:19 AMARWR+0.51%MDGL+1.50%
